FIELD: medicine.
SUBSTANCE: invention refers to experimental medicine and concerns drug-free blood hyperglycemia relief in experimental animals. For this purpose, beetroot pectin in the amount of 100 mcg/kg a day is introduced into the diet of inbred white rats simultaneously with the atherogenic diet.
EFFECT: method provides decreasing the hyperlipidaemia level ensured by reducing total cholesterol, triglycerides, very low density lipoprotein (VLDLP) and low-density lipoproteins (LDLP) in animal's blood.
1 tbl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF NON-DRUG REDUCTION OF HYPERLIPIDEMIA | 2010 |
|
RU2454973C1 |
PHARMACEUTICAL COMBINATION POSSESSING ANTIAGGREGANT AND LIPID-REGULATING ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2461379C2 |
AGENT FOR METABOLIC SYNDROME CORRECTION | 2011 |
|
RU2458935C1 |
AGENT WITH HYPOLIPIDEMIC ACTIVITY | 2004 |
|
RU2268714C1 |
ANTI-ISCHEMIC AND ANTI-ATHEROSCLEROTIC DRUG | 1998 |
|
RU2144822C1 |
COMBINATION POSSESSING ANTIAGGREGANT, LIPID-REGULATING AND GASTROPROTECTIVE ACTIVITIES, PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2453314C1 |
AGENT BASED ON L-RHAMNOPYRANOSYL-6-O-METHYL-D-GALACTURONANE, HAVING HYPOLIPIDEMIC ACTIVITY | 2019 |
|
RU2699802C1 |
HYPOLIPIDEMIC AGENT | 2008 |
|
RU2392933C2 |
METHOD OF NONMEDICAMENTOUS HYPERLIPIDEMIA DECREASE | 2007 |
|
RU2346699C1 |
AGENT POSSESSING HYPOLIPIDEMIC AND ANTIATHEROSCLEROTIC ACTIVITY | 2015 |
|
RU2598347C1 |
Authors
Dates
2013-10-10—Published
2012-02-27—Filed